SCHEMBL30906002

SCHEMBL30906002

C[C@@H](O)[C@H](N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)O)[C@@H](C)O

nearest known ligand 0.63

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
SLC6A2 P23975 2/20 0.57
EPHA2 P29317 2/20 0.54
NTSR2 O95665 3/20 0.52
NTSR1 P30989 3/20 0.52
OPRM1 P35372 1/20 0.52
OPRD1 P41143 1/20 0.52
SORT1 Q99523 2/20 0.51
NMUR2 Q9GZQ4 2/20 0.51
NMUR1 Q9HB89 2/20 0.51
RAMP3 O60896 1/20 0.51
CALCR P30988 1/20 0.51
NPY1R P25929 1/20 0.50
KISS1R Q969F8 2/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30690151 0.94 SLC6A2 (0.55) SLC6A2EPHA2NTSR2NTSR1OPRM1
SCHEMBL30906001 0.92 SLC6A2 (0.59) SLC6A2EPHA2NTSR2NTSR1OPRM1
SCHEMBL30953198 0.91 SLC6A2 (0.62) SLC6A2EPHA2NTSR2NTSR1OPRM1
SCHEMBL30906006 0.90 NTSR1 (0.57) SLC6A2NTSR2NTSR1SORT1
SCHEMBL30823901 0.88 EPHA2 (0.50) SLC6A2EPHA2NTSR2NTSR1SORT1
SCHEMBL30953205 0.88 SLC6A2 (0.59) SLC6A2EPHA2NTSR2NTSR1SORT1
SCHEMBL30953193 0.88 SLC6A2 (0.59) SLC6A2EPHA2NTSR2NTSR1SORT1
SCHEMBL31415963 0.88 EPHA2 (0.62) SLC6A2EPHA2NTSR2NTSR1OPRM1
SCHEMBL30906005 0.88 NTSR1 (0.60) NTSR2NTSR1OPRD1SORT1NPY1R
SCHEMBL30690152 0.87 SLC6A2 (0.67) SLC6A2EPHA2OPRM1OPRD1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4622672-A1 AMYLIN ANALOGUES IP2IPO Innovations Limited (GB) 2025-10-01 EP disclosed
WO-2024110763-A1 AMYLIN ANALOGUES IP2IPO INNOVATIONS LIMITED (GB) 2024-05-30 WO disclosed